Form D · Biotechnology
Harton, Inc.
Melrose, MA · CIK 0002149866
Offering snapshot reported Aug 14, 2026 · SEC filing
- Reported sold
- $15.1M Offering amount: $18.1M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 30, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 14, 2026 | Initial | $15,099,998 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-594356
Source: Form D, filed Aug 14, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Min Cui | Director |
| Evan Daugharthy | Director |
| Richard Terry | Director, Executive |
| Victor Tong | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
616 Main Street
Melrose, MA, 02176
Phone: 617 388-0617
Melrose, MA, 02176
Phone: 617 388-0617